BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 1020683)

  • 1. A retrospective evaluation of long-term fluspirilene (IMAP) treatment.
    Tanghe A
    Acta Psychiatr Belg; 1976 May; 76(3):480-90. PubMed ID: 1020683
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fluspirilene (Imap) in the treatment of psychosomatic complaints in hypochondriacal patients.
    Kalis D; Ten Oever GH; Erdmann JF
    Acta Psychiatr Belg; 1980; 80(3):321-8. PubMed ID: 7211423
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A controlled clinical trial of fluspirilene, a long-acting injectable neuroleptic, in schizophrenic patients with acute exacerbation.
    Chouinard G; Annable L; Steinberg S
    J Clin Psychopharmacol; 1986 Feb; 6(1):21-6. PubMed ID: 3512622
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A double-blind clinical evaluation of different dose intervals with fluspirilene (IMAP).
    Börger J; Van Epen JH; Dekkers A
    Acta Psychiatr Belg; 1978; 78(2):383-91. PubMed ID: 354325
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fluspirilene in the treatment of non-hospitalized schizophrenic patients.
    Soni SD
    Curr Med Res Opin; 1977; 4(9):645-9. PubMed ID: 590024
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A comparative study of the longacting neuroleptics perphenazin-enanthate and fluspirilene (author's transl)].
    Tegeler J; Floru L
    Pharmakopsychiatr Neuropsychopharmakol; 1979 Sep; 12(5):357-65. PubMed ID: 504342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Utilization and safety of fluspirilene in nonpsychotic outpatients.
    Schmidt LG
    Pharmacopsychiatry; 1989 Sep; 22(5):188-91. PubMed ID: 2813507
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fluspirilene: a long-acting injectable neuroleptic.
    Drug Ther Bull; 1977 Jul; 15(15):59-60. PubMed ID: 330126
    [No Abstract]   [Full Text] [Related]  

  • 9. [Depression following use of Imap 1.5 mg].
    Kiltz RR
    MMW Munch Med Wochenschr; 1981 Apr; 123(15):611-2. PubMed ID: 6785595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Fluspirilen and fluphenazine in schizophrenic patients. Comparative study].
    Magnus RV
    MMW Munch Med Wochenschr; 1980 Dec; 122(49):1758-60. PubMed ID: 6779147
    [No Abstract]   [Full Text] [Related]  

  • 11. A double-blind comparison of fluspirilene and fluphenazine decanoate in schizophrenia.
    Russell N; Landmark J; Merskey H; Turpin T
    Can J Psychiatry; 1982 Nov; 27(7):593-6. PubMed ID: 7172160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Fluspirilene in schizophrenia maintenance therapy and its interaction with dexetimide].
    Skopová J; Faltus F; Filip V; Jirák R; Karen P; Posmurová M; Dobiásová A
    Cesk Psychiatr; 1985 Dec; 81(6):414-9. PubMed ID: 3912068
    [No Abstract]   [Full Text] [Related]  

  • 13. Double-blind therapeutic evaluation of fluspirilene compared with fluphenazine decanoate in chronic schizophrenics.
    Frangos H; Zissis NP; Leontopoulos I; Diamantas N; Tsitouridis S; Gavriil I; Tsolis K
    Acta Psychiatr Scand; 1978 May; 57(5):436-46. PubMed ID: 354331
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Alternative therapy concept for the treatment of psychosomatic disorders. Controlled double-blind evaluation of fluspirilene versus bromazepam].
    Lehmann E; Hassel P; Thörner GW; Karrass W
    Fortschr Med; 1984 Oct; 102(40):1033-6. PubMed ID: 6149989
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The depot compounds moditen (fluphenazine) and IMAP (fluspirilene) in clinical practice.
    Faltus F
    Act Nerv Super (Praha); 1974 Aug; 16(3):167-8. PubMed ID: 4607824
    [No Abstract]   [Full Text] [Related]  

  • 16. [Experience with fluspirilene in gerontopsychiatry (author's transl)].
    Kanowski S; Paur R
    Pharmakopsychiatr Neuropsychopharmakol; 1980 May; 13(3):137-43. PubMed ID: 7393999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Long-term tranquilizers - an alternative in medical practice (author's transl)].
    Pach J; Waniek W
    Arzneimittelforschung; 1976; 26(6):1189-90. PubMed ID: 786318
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Treatment of functional heart diseases with Imap 1.5 mg in daily practice].
    Sebald C
    MMW Munch Med Wochenschr; 1982 Aug; 124(31):698-700. PubMed ID: 6811878
    [No Abstract]   [Full Text] [Related]  

  • 19. [New long-acting treatment of anxiety and its different forms of somatization: low-dose fluspirilene].
    Giannelli A; Zarattini F
    Minerva Med; 1983 Mar; 74(13):727-33. PubMed ID: 6835561
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Depot neuroleptics in social psychiatric practice].
    Pruss U; Rose HK; Zechner A
    Psychiatr Prax; 1984 Jul; 11(4):101-8. PubMed ID: 6148764
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.